ClinicalTrials.gov
public full text
Public Domain
Efficacy and Safety Study of LAS41007 in the Treatment of Actinic Keratosis
The aim of this study is to determine the efficacy, safety and tolerability of either a once or twice daily topical application of LAS41007 compared to a twice daily application of LAS106521 in the treatment of actinic keratosis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Role of General Practitioners in Actinic Keratosis Management in Europe: A Dermato-Oncologists Initiative / Claas Ulrich, Markus V. Heppt, Giuseppe Argenziano, Maria Concetta Fargnoli, Carla Ferrándiz-Pulido, Thomas Jouary, Aimilios Lallas, César Martins, Klara Mosterd, Philippe Saiag, Nathalie Bégeault, Alba Crespo-Cruz ; Herausgeber: Stamatis Gregoriou#675497
- Study on the Efficacy of LAS41005 in the Treatment of Actinic Keratosis#825296
- ADL-PDT Under Routine Clinical Conditions in Patients With Actinic Keratosis#993850
- A Study to Evaluate Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment Period#1088362
- Long Term Efficacy and Safety of Eryfotona AK-NMSC® in Patients With Actinic Keratosis#1153084
Record · ID 886485
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive